In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425
…, K Steiner, J Haunschild, S Möllenstädt… - Cancer Immunology …, 1996 - Springer
In order to study the potential of non-invasive scintigraphic evaluation of the epidermal growth
factor (EGF) receptor status in vivo, the biokinetics and tumor binding of 125 I-EGF and anti…
factor (EGF) receptor status in vivo, the biokinetics and tumor binding of 125 I-EGF and anti…
[PDF][PDF] Curative radioimmunotherapy of human mammary carcinoma xenografts with iodine-131-labeled monoclonal antibodies
R Senekowitsch, G Reidel, S Möllenstädt… - Journal of nuclear …, 1989 - Soc Nuclear Med
Gy resultingin a mean reductionin tumordiameterof 50%, correspondingto a reductionin
tumorvolumeof88% within42daysp. i. UnlabeledMoAbhadnoeffectontumorgrowth compared with …
tumorvolumeof88% within42daysp. i. UnlabeledMoAbhadnoeffectontumorgrowth compared with …
[CITATION][C] Evaluation of Epidermal Growth Factor Receptors on Human Tumor Xenografts by MAb 425 and Its Fragments
…, B Gunsenheimer, S Möllenstädt… - … Animals: Models for …, 1996 - karger.com
The epidermal growth factor (EGF) receptor is a transmembrane glycoprotein, and the
receptor expression has been described on tumor cells of diverse tissue origin. The binding of …
receptor expression has been described on tumor cells of diverse tissue origin. The binding of …
[PDF][PDF] Mammary Carcinoma Xenografts with
HW Pabst - J Nucl Med, 1989 - Citeseer
Gy resultingin a mean reductionin tumordiameterof 50%, correspondingto a reductionin
tumorvolumeof88% within42daysp. i. UnlabeledMoAbhadnoeffectontumorgrowth compared with …
tumorvolumeof88% within42daysp. i. UnlabeledMoAbhadnoeffectontumorgrowth compared with …